About

About iProcess Global Research Inc iProcess Global Research Inc. is a leading global provider of biospecimens and laboratory services, with over 20 years of experience and a global network of over 1500 sites. iProcess Global Research Inc. is a leading global provider of high-quality human biospecimens and comprehensive laboratory services, dedicated to empowering scientific research and accelerating medical breakthroughs. With more than 22 years of experience supporting the life sciences, pharmaceutical, biotechnology, and diagnostic industries, iProcess connects researchers to ethically sourced, clinically annotated human biospecimens through a robust network of 1,500+ pre-qualified clinical sites across over 30+ countries. Built on a foundation of strict regulatory compliance and quality excellence—including ISO 20387 and CAP/CLIA-aligned workflows—iProcess offers end-to-end solutions ranging from customized specimen collection and validated cold-chain logistics to advanced, AI-enhanced laboratory analysis and project management support. iProcess’s global biorepository and laboratory ecosystem provides seamless access to a broad range of human sample types and disease cohorts, enabling organizations to navigate complex research requirements with reliability, flexibility, and scientific integrity. Whether supporting clinical trial biospecimen procurement or delivering integrated lab services, iProcess is committed to advancing research and delivering data researchers can trust. As part of its continued expansion in laboratory services, iProcess is launching AxisOne.ai in February 2026—an AI-powered global R&D platform designed to connect organizations with world-class laboratories and research capabilities worldwide. AxisOne leverages artificial intelligence and deep analytics to accelerate feasibility, optimize lab selection, and streamline execution for specialized testing needs by bringing hundreds of labs and research sites onto a single intelligent platform.